Cargando…

Real‐world prevalence of the inclusion criteria for the LEADER trial: Data from a national general practice network

AIMS: To explore the prevalence and describe the clinical characteristics of people with type 2 diabetes with a similar cardiovascular (CV) profile to that of the LEADER trial participants in a primary care setting in England. MATERIALS AND METHODS: In this cross‐sectional analysis, using the Royal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hinton, William, Feher, Michael, Munro, Neil, Walker, Megan, de Lusignan, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619442/ https://www.ncbi.nlm.nih.gov/pubmed/30900349 http://dx.doi.org/10.1111/dom.13710

Ejemplares similares

Does Real World Use of Liraglutide Match its Use in the LEADER Cardiovascular Outcome Trial? Study Protocol
por: Hinton, William, et al.
Publicado: (2018)

Fenofibrate as a COVID-19 modifying drug: Laboratory success versus real-world reality
por: Feher, Michael, et al.
Publicado: (2021)

How Generalizable Are Cardiovascular Outcome Trials of Sodium-Glucose Co-Transporter-2 Inhibitors? A National Database Study: Study Protocol
por: Hinton, William, et al.
Publicado: (2019)

Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use
por: McGovern, Andrew, et al.
Publicado: (2017)

Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study)
por: Feher, Michael, et al.
Publicado: (2022)

Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors: Comparing Trial and Real World Use (Study Protocol)
por: McGovern, Andrew, et al.
Publicado: (2017)

Does Renal Function or Heart Failure Diagnosis Affect Primary Care Prescribing for Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes?
por: Hinton, William, et al.
Publicado: (2020)

Obstructive sleep apnoea in Type 2 diabetes mellitus: increased risk for overweight as well as obese people included in a national primary care database analysis
por: Feher, M., et al.
Publicado: (2019)

Real-world evidence studies into treatment adherence, thresholds for intervention and disparities in treatment in people with type 2 diabetes in the UK
por: McGovern, Andrew, et al.
Publicado: (2016)

Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis
por: Hinton, William, et al.
Publicado: (2021)

Intensification to injectable therapy in type 2 diabetes: mixed methods study (protocol)
por: de Lusignan, Simon, et al.
Publicado: (2019)

Sodium–glucose co‐transporter‐2 inhibitor cardiovascular outcome trials and generalizability to English primary care
por: Hinton, W., et al.
Publicado: (2020)

Improving the Management of Atrial Fibrillation in General Practice: Protocol for a Mixed Methods Study
por: de Lusignan, Simon, et al.
Publicado: (2020)

How to Be an Inclusive Leader
por: Brown, Jennifer
Publicado: (2019)

Real Women, Real Leaders: Surviving and Succeeding in the Business World
por: Hurley, Kathleen
Publicado: (2015)

Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolism
por: Hinton, William, et al.
Publicado: (2020)

Variation in the diagnosis and control of hypertension is not explained by conventional variables: Cross-sectional database study in English general practice
por: Coyle, Rachel, et al.
Publicado: (2019)

The 5 Disciplines of Inclusive Leaders
por: Tapia, Andrés
Publicado: (2020)

Systematic review of adherence rates by medication class in type 2 diabetes: a study protocol
por: McGovern, Andrew, et al.
Publicado: (2016)

A Class Comparison of Medication Persistence in People with Type 2 Diabetes: A Retrospective Observational Study
por: McGovern, Andrew, et al.
Publicado: (2018)

Atrial fibrillation dashboard evaluation using the think aloud protocol
por: de Lusignan, Simon, et al.
Publicado: (2020)

Designing Inclusive Systems: Designing Inclusion for Real-world Applications
por: Langdon, Patrick, et al.
Publicado: (2012)

Inclusion of Older People Reflective of Real‐World Clinical Practice in Cardiovascular Drug Trials
por: Caughey, Gillian E., et al.
Publicado: (2020)

The President as world leader
por: Kellerman, Barbara
Publicado: (1991)

Cardiovascular Profile of Patients with Type 2 Diabetes in France Based on REWIND CVOT Inclusion Criteria: A Real-World Retrospective Study
por: Dib, Anne, et al.
Publicado: (2022)

The inclusion of real world evidence in clinical development planning
por: Martina, Reynaldo, et al.
Publicado: (2018)

The impact of illness on world leaders
por: Loudon, Irvine
Publicado: (1988)

Adherence to General Diabetes and Foot Care Processes, with Prompt Referral, Are Associated with Amputation-Free Survival in People with Type 2 Diabetes and Foot Ulcers: A Scottish National Registry Analysis
por: Meza-Torres, Bernardo, et al.
Publicado: (2022)

Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods Study
por: de Lusignan, Simon, et al.
Publicado: (2022)

Methods for the inclusion of real-world evidence in network meta-analysis
por: Jenkins, David A., et al.
Publicado: (2021)

An inclusive, real-world investigation of persuasion in language and verbal behavior
por: Ta, Vivian P., et al.
Publicado: (2021)

Incidence and prevalence of cardiovascular disease in English primary care: a cross-sectional and follow-up study of the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC)
por: Hinton, William, et al.
Publicado: (2018)

Equity, Diversity, and Inclusion moments to raise Equity, Diversity, and Inclusion literacy among physician leaders
por: Ruzycki, Shannon M, et al.
Publicado: (2023)

Leaders in Computing: Changing the digital world
por: Knuth, Donald, et al.
Publicado: (2011)

Real-world validation of the 2017 McDonald criteria for pediatric MS
por: Wong, Yu Yi M., et al.
Publicado: (2018)

Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria
por: Harmanen, Minna, et al.
Publicado: (2023)

US Medical School Admissions Leaders’ Experiences With Barriers to and Advancements in Diversity, Equity, and Inclusion
por: Ko, Michelle, et al.
Publicado: (2023)

Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis
por: Whyte, Martin B., et al.
Publicado: (2019)

Proposal for the SOSORT inclusion criteria for studies on physiotherapy
por: Weiss, HR, et al.
Publicado: (2012)

Inclusion and Exclusion Criteria of Clinical Trials for Insomnia
por: Huls, Hendrikje, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_32eani7o9334raifmek0l7gqp0